Medicare Enrolled
Dr. Leonard Gitter, MD
Medical Oncology · Lakeland, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gitter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gitter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gitter
Dr. Leonard Gitter is a medical oncology specialist in Lakeland, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Gitter performed 191,468 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gitter received a total of $2,683 from 30 pharmaceutical and/or device companies across 121 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gitter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 13% volume in FL
$2,683 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 140485 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗191,468
Medicare services
Top 13% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
101,250 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 36,000 | $43 | $124 |
| Paclitaxel chemotherapy injection | 12,099 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 11,640 | $19 | $49 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
8,560 | $6 | $24 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,150 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,319 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,541 | $1 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,207 | $97 | $194 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,126 | $64 | $132 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
840 | $98 | $338 |
| Injection, leucovorin calcium, per 50 mg | 801 | $3 | $14 |
| Anti-nausea injection (ondansetron/Zofran) | 776 | $0 | $1 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
606 | $2 | $7 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
518 | $22 | $77 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
512 | $11 | $50 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
435 | $2 | $11 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
333 | $54 | $177 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 333 | $135 | $562 |
| Injection, triptorelin pamoate, 3.75 mg | 282 | $299 | $1,000 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
201 | $24 | $81 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
195 | $22 | $71 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
193 | $63 | $133 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
191 | $17 | $61 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
181 | $47 | $168 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
164 | $49 | $161 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
134 | $82 | $197 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
117 | $1 | $3 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
112 | $19 | $50 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
109 | $136 | $372 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
108 | $42 | $154 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
79 | $134 | $262 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $116 | $300 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
52 | $15 | $51 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
49 | $130 | $344 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
44 | $12 | $55 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
44 | $2 | $7 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
39 | $1 | $6 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
31 | $25 | $139 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
22 | $17 | $36 |
| New patient office visit, complex (60-74 min) | 21 | $166 | $377 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
53.8% high complexity
44.3% medium
1.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,683
Total received (2018-2024)
Avg $671/year across 4 years
Bottom 35% in FL for medical oncology
30
Companies
121
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,655
2023
$906
2019
$97
2018
$26
Payments by company (2024)
PFIZER INC.
$218
Novartis Pharmaceuticals Corporation
$170
Daiichi Sankyo Inc.
$169
GENZYME CORPORATION
$130
Incyte Corporation
$112
Celgene Corporation
$92
Gilead Sciences, Inc.
$80
Janssen Biotech, Inc.
$76
Blueprint Medicines Corporation
$70
Eisai Inc.
$63
ABBVIE INC.
$51
AstraZeneca Pharmaceuticals LP
$50
Verity Pharmaceuticals Inc.
$49
ARRAY BIOPHARMA INC
$47
E.R. Squibb & Sons, L.L.C.
$46
SHIELD THERAPEUTICS INC
$37
Genentech USA, Inc.
$36
Astellas Pharma US Inc
$33
Lilly USA, LLC
$30
ADC Therapeutics America, Inc.
$29
Merck Sharp & Dohme LLC
$26
GlaxoSmithKline, LLC.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$17
Top 3 companies account for 33.7% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$406
GENZYME CORPORATION
$309
Novartis Pharmaceuticals Corporation
$274
Daiichi Sankyo Inc.
$209
Incyte Corporation
$142
AstraZeneca Pharmaceuticals LP
$113
Blueprint Medicines Corporation
$104
Amgen Inc.
$93
Celgene Corporation
$92
Astellas Pharma US Inc
$90
Gilead Sciences, Inc.
$80
Janssen Biotech, Inc.
$76
Genentech USA, Inc.
$72
ARRAY BIOPHARMA INC
$71
Eisai Inc.
$63
ABBVIE INC.
$51
Verity Pharmaceuticals Inc.
$49
ADC Therapeutics America, Inc.
$47
E.R. Squibb & Sons, L.L.C.
$46
Merck Sharp & Dohme LLC
$45
SHIELD THERAPEUTICS INC
$37
Takeda Pharmaceuticals U.S.A., Inc.
$37
Lilly USA, LLC
$30
Myriad Genetic Laboratories, Inc.
$23
AVEO Pharmaceuticals, Inc.
$23
GlaxoSmithKline, LLC.
$21
Stemline Therapeutics Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Karyopharm Therapeutics Inc.
$19
Amneal Pharmaceuticals LLC
$18
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AUGTYRO · AVASTIN · AYVAKIT · BOSULIF · Blincyto · CABLIVI · CALQUENCE · DARZALEX · ELAHERE · ENHERTU · ENJAYMO · Enhertu · FOTIVDA · IBRANCE · ICLUSIG · INLYTA · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LORBRENA · LUMAKRAS · Lenvima · MEKINIST · MYRISK · Nplate · Nubeqa · OJJAARA · OPDIVO · OXBRYTA · Orserdu · PIQRAY · PLUVICTO · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · SARCLISA · SCEMBLIX · Tecentriq · Trelstar · VENCLEXTA · VERZENIO · Vanflyta · XPOVIO · XTANDI · Xospata
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
8
County median income
$63,644
Nearest hospital to ZIP centroid (approximate)
LAKELAND REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gitter is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gitter experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Gitter performed 101,250 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gitter receive payments from pharmaceutical companies?
Yes. Dr. Gitter received a total of $2,683 from 30 companies across 121 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gitter's costs compare to other medical oncologists in Lakeland?
Dr. Gitter's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gitter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Lakeland
Browse medical oncologists in Lakeland ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology